Concepedia

Publication | Open Access

696O_PR Nivolumab + cabozantinib vs sunitinib in first-line treatment for advanced renal cell carcinoma: First results from the randomized phase III CheckMate 9ER trial

DOIFull Paper Access

116

Citations

0

References

2020

Year

Toni K. Choueiri, Thomas Powles, Mauricio Burotto, María T. Bourlon, Bogdan Żurawski, Víctor Manuel Oyervides-Juárez, James J. Hsieh, Umberto Basso, Amishi Y. Shah, Cristina Suárez,
Annals of Oncology

No additional data available for this publication yet. Check back later!